J. Francis

发表

Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94

R. E. Edwards, B. Dorman, A. Smith, 1994, Biometals.

Induction of 8-hydroxydeoxyguanosine in Ah-responsive mouse liver by iron and Aroclor 1254.

J. Chipman, A. Smith, S. Faux, 1992, Carcinogenesis.

Iron as a synergist for hepatocellular carcinoma induced by polychlorinated biphenyls in Ah-responsive C57BL/10ScSn mice.

Andrew G Smith, P. Carthew, A. Smith, 1990, Carcinogenesis.

Incomplete correlation of 2,3,7,8-tetrachlorodibenzo-p-dioxin hepatotoxicity with Ah phenotype in mice.

J. B. Greig, A. Smith, D. Lovell, 1984, Toxicology and applied pharmacology.

Hepatic toxicity and uroporphyrinogen decarboxylase activity following a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin to mice.

J. B. Greig, A. Smith, J. Francis, 1981, Biochemical pharmacology.

The induction of benzo[a]pyrene-3-mono-oxygenase by singlet oxygen in liver cell culture is mediated by oxidation products of histidine.

A. Paine, J. Francis, 1980, Chemico-biological interactions.

Pleiotropic effect of the gene hairless on hepatotoxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in mice

D. Ray, J. B. Greig, A. Smith, 1987, Archives of Toxicology.

Distinction between octachlorostyrene and hexachlorobenzene in their potentials to induce ethoxyphenoxazone deethylase and cause porphyria in rats and mice.

A. Smith, I. Bird, J. Francis, 1986, Journal of biochemical toxicology.

Carcinogenicity of iron in conjunction with a chlorinated environmental chemical, hexachlorobenzene, in c57bl/10scsn mice

Andrew G Smith, P. Carthew, M. Manson, 1989, International journal of cancer.

Continued depression of hepatic uroporphyrinogen decarboxylase activity caused by hexachlorobenzene or 2,3,7,8-tetrachlorodibenzo-p-dioxin despite regeneration after partial hepatectomy.

J. B. Greig, A. Smith, J. Francis, 1985, Biochemical pharmacology.

CGS 21680 : a potent selective adenosine A2 receptor agonist

J. Balwierczak, R. Webb, M. Sills, 1992 .

Chapter 7. Antihypertensive Agents

J. Francis, 1974 .

Influence of iron on the induction of hepatic tumors and porphyria by octachlorostyrene in C57BL/10ScSn mice.

A. Smith, K. Ingebrigtsen, P. Carthew, 1994, Cancer letters.

Genetic variation of iron-induced uroporphyria in mice.

A. Smith, J. Francis, A. Smith, 1993, The Biochemical journal.

Chapter 7. Cardiovascular Agents

J. Francis, 1975 .

Rapid induction of hepatic fibrosis in the gerbil after the parenteral administration of iron‐dextran complex

Andrew G Smith, P. Carthew, B. Dorman, 1991, Hepatology.

A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron overload.

P. Carthew, R. E. Edwards, B. Dorman, 1993, Laboratory investigation; a journal of technical methods and pathology.

Oxidation of uroporphyrinogens by hydroxyl radicals Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decar☐ylase

A. Smith, Andrew G. Smith, J. Francis, 1988, FEBS letters.

Synergy of iron in the toxicity and carcinogenicity of polychlorinated biphenyls (PCBs) and related chemicals.

A. Smith, B. Clothier, P. Carthew, 1995, Toxicology letters.

Measles in Australasian indigenes.

D. Gajdusek, J. Francis, B. R. Adels, 1962, American journal of diseases of children.

Evidence for the active renal secretion of S-pentachlorophenyl-N-acetyl-L-cysteine by female rats.

A. Smith, J. Francis, A. Smith, 1983, Biochemical pharmacology.

Anxiolytic properties of certain annelated [1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-ones.

D. A. Bennett, D. Murphy, J. L. Hyun, 1991, Journal of medicinal chemistry.

Synthesis and benzodiazepine binding activity of a series of novel [1,2,4]triazolo[1,5-c]quinazolin-5(6H)-ones.

R. A. Lovell, W. D. Cash, J. L. Hyun, 1991, Journal of medicinal chemistry.

Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase.

A. Smith, J. Francis, A. Smith, 1979, The Biochemical journal.

Absorption Spectrum of Matrix‐Isolated Ca Atoms

S. Webber, J. Francis, 1972 .

Characterization and accumulation of ferritin in hepatocyte nuclei of mice with iron overload

Andrew G Smith, D. Dinsdale, P. Carthew, 1990, Hepatology.

Substrate-dependent irreversible inactivation of cytochrome P-450: conversion of its haem moiety into modified porphyrins.

L. Cantoni, F. De Matteis, A. Gibbs, 1980, Ciba Foundation symposium.

Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice.

A. Smith, J. Francis, A. Smith, 1983, The Biochemical journal.

Investigations of rat liver uroporphyrinogen decarboxylase. Comparisons of porphyrinogens I and III as substrates and the inhibition by porphyrins.

A. Smith, J. Francis, 1981, The Biochemical journal.

Participation of Isolated Double Bonds in the Cleavage of Peptides with N-Bromosuccinimide

A. V. Robertson, N. Izumiya, B. Witkop, 1962 .

ORGANIC DEUTERIUM COMPOUNDS: XVII. A SYNTHESIS OF DEUTERATED METHYL CHLOROFORM

L. C. Leitch, J. Francis, 1957 .

Modulation by iron of hepatic microsomal and nuclear cytochrome P450, and cytosolic glutathione S-transferase and peroxidase in C57BL/10ScSn mice induced with polychlorinated biphenyls (Aroclor 1254).

M. Manson, A. Smith, F. Mann, 1996, Toxicology and applied pharmacology.

Porphyrin analysis by reversed-phase high-performance liquid chromatography: biomedical applications

Andrew G Smith, J. Francis, 1985 .

Assay of mouse liver uroporphyrinogen decarboxylase by reverse-phase high-performance liquid chromatography.

A. Smith, J. Francis, A. Smith, 1984, Analytical biochemistry.

Protoporphyria induced by the orally active iron chelator 1,2-diethyl-3-hydroxypyridin-4-one in C57BL/10ScSn mice.

R. Hider, F. De Matteis, A. Smith, 1997, Blood.

Genetic variation of basal iron status, ferritin and iron regulatory protein in mice: potential for modulation of oxidative stress.

A G Smith, R. Akhtar, S. Robinson, 2000, Biochemical pharmacology.

Sex-linked hepatic uroporphyria and the induction of cytochromes P450IA in rats caused by hexachlorobenzene and polyhalogenated biphenyls.

Andrew G Smith, C. Wolf, J. B. Greig, 1990, Biochemical pharmacology.

Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload.

A. Smith, J. Francis, A. Smith, 1987, The Biochemical journal.

Uroporphyria induced by 5-aminolaevulinic acid alone in Ahrd SWR mice.

R. Akhtar, A. Smith, B. Clothier, 1996, Biochemical pharmacology.

Increased inhibition of hepatic uroporphyrinogen decarboxylase by hexachlorobenzene in male rats given the oestrogenic drugs diethylstilboestrol and chlorotrianisene.

A. Smith, J. Francis, 1981, Biochemical pharmacology.

Lobes of rat liver respond at different rates to challenge by dietary hexachlorobenzene.

F. De Matteis, A. Smith, J. Francis, 1980, Biochemical pharmacology.

Sexual dimorphism of cytochrome P-450 induction by hexachlorobenzene in rats.

C. Wolf, M. Manson, A. Smith, 1989, Biochemical Society transactions.

Polycyclic aromatic hydrocarbons cause hepatic porphyria in iron-loaded C57BL/10 mice: comparison of uroporphyrinogen decarboxylase inhibition with induction of alkoxyphenoxazone dealkylations.

A. Smith, J. Francis, 1987, Biochemical and biophysical research communications.

Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria.

D. Dinsdale, M. Manson, A. Smith, 1985, Carcinogenesis.

Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.

J. B. Greig, A. Smith, J. Francis, 1986, The Biochemical journal.

Genetic, iron status and sex factors of porphyria induced by hexachlorobenzene.

A. Smith, J. Francis, F. P. Stewart, 1986, IARC scientific publications.

Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists.

G. Ghai, V. Warren, W. D. Cash, 1988, Journal of medicinal chemistry.

Rearrangements of Dehydroproline Derivatives

A. V. Robertson, B. Witkop, J. Francis, 1962 .

The glutathione-linked metabolism of 2-allyl-2-isopropy-lacetamide in rats. Further evidence for the formation of a reactive metabolite.

F. De Matteis, P. Edwards, J. Francis, 1978, Chemico-biological interactions.

Enhancement by iron of hepatic neoplasia in rats caused by hexachlorobenzene.

M. Manson, A. Smith, J. Cabral, 1993, Carcinogenesis.

Protection against iron-induced uroporphyria in C57BL/10ScSn mice by the peroxisome proliferator nafenopin.

D. G. Walters, B. Lake, J. Francis, 1990, Biochemical pharmacology.

Rapid induction of hepatic fibrosis in the gerbil after the parenteral administration of iron‐dextran complex

Andrew G Smith, P. Carthew, B. Dorman, 1991, Hepatology.

Highly selective adenosine A2 receptor agonists in a series of N-alkylated 2-aminoadenosines.

G. Ghai, R. Webb, R. Dejesus, 1991, Journal of medicinal chemistry.

Masculinizing tumor of the ovary, apparently with adrenocortical activity a histologic, ultrastructural, and biochemical study

L. Koss, M. Fleisher, E. Rothschild, 1969, Cancer.

A convenient synthesis of 3,5-disubstituted-1,2,4-triazoles

H. Meckler, J. Francis, G. Mazzenga, 1987 .

A Convenient Synthesis of 3,5-Disubstituted 1,2,4-Triazoles.

H. Meckler, J. Francis, G. Mazzenga, 1988 .

Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.

R. Webb, J. Peppard, M. Sills, 1993, The Journal of pharmacology and experimental therapeutics.

Osborn waves in sepsis.

Gustavo A. Cardenas, H. Ventura, J. Francis, 2006, Southern medical journal.